Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.

05 Aug 2022
0
0

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.

Tags

Share this

Related Posts

Bhinija, K.; Srifah Huehne, P.; Prawat, H.; Ruchirawat, S.; Saimanee, B.; Mongkolsuk, S.; Satayavivad, J. The Rhizome of Bulbophylllum orchid is the Rich Source of Cytotoxic Bioactive Compounds, the Potential Anticancer Agents. S. Afr. J. Bot. 2021, 141, 367-372.
01 Sep 2021
0

Bhinija, K.; Srifah Huehne, P.; Prawat, H.; Ruchirawat, S.; Saimanee, B.; Mongkolsuk, S.; Satayavivad, J. The Rhizome of Bulbophylllum orchid is the Rich Source of Cytotoxic Bioactive Compounds, the Potential Anticancer Agents. S. Afr. J. Bot. 2021, 141, 367-372.

Bhinija, K.; Srifah Huehne, P.; Prawat, H.; Ruchirawat, S.; Saimanee, B.; Mongkolsuk, S.; Satayavivad, J. The Rhizome of Bulbophylllum orchid is the Rich Source of Cytotoxic Bioactive Compounds, the Potential Anticancer Agents. S. Afr. J. Bot. 2021, 141, 367-372.
View More

Recent Posts